PubMed · 2011 · 57 citations · 27 references
MedicineOncologyPharmacologyMolecular OncologyMolecular PharmacologySignal TransductionApoptosis In CancerBreast Cancer PharmacotherapyNuclear Receptor SignalingCancer Cell Proliferation InhibitionMitogen-activated Protein Kinase CascadesMitogen-activated Protein Kinase ModulationPeroxisome Proliferator-activated Receptor Gamma AgonismPeroxisome Proliferator-activated Receptor Gamma RegulationPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated ReceptorsSignaling
BACKGROUND: Peroxisome proliferator-activated receptor gamma (PPARγ) is overexpressed in many types of cancer, including breast cancer, and it is regulated by ligand binding and post-translational modifications. It was previously demonstrated that endogenous transactivation promotes an aggressive phenotype of malignant breast cells. This study examines whether selective antagonism of PPARγ with T0070907 is a potential strategy for breast cancer therapy. MATERIALS AND METHODS: PPARγ activation was inhibited using both pharmacological and molecular approaches and proliferation, apoptosis, migration and invasion were measured in MDA-MB-231 and MCF-7 breast cancer cells. RESULTS: T0070907 treatment inhibited proliferation, invasion and migration but did not significantly affect apoptosis. Molecular inhibition using a dominant negative (Δ462) receptor yielded similar results. T007 also mediated a dose-dependent decrease in phosphorylation of PPARγ, and its ability to bind to DNA, and may directly affect mitogen-activated protein kinase signaling. CONCLUSION: These data indicate that inhibiting endogenous PPARγ signaling may be a promising new approach to breast cancer therapy.
27
FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly
Donna J. Webb, Karen Donais, Leanna Whitmore et al. · Nature Cell Biology · 2004 · 1.4K citations
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Naoto Kubota, Yasuo Terauchi, Hiroshi Miki et al. · Molecular Cell · 1999 · 1.4K citations · Full text
Terminal Differentiation of Human Breast Cancer through PPARγ
Elisabetta Mueller, Pasha Sarraf, Peter Tontonoz et al. · Molecular Cell · 1998 · 844 citations · Full text